LifeStance Health Group, Inc. (LFST)
Healthcare • Medical Care Facilities
StockNasdaqGSUnited StatesUS53228F1012
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by LifeStance Health Group, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 10:53. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 25 Feb 2027 08:00 | 0.09 | — | — | Upcoming |
| 05 Nov 2026 06:00 | 0.08 | 0.11 | +26.7% | Beat |
| 06 Aug 2026 06:00 | 0.08 | 0.11 | +32.4% | Beat |
| 07 May 2026 06:00 | 0.06 | 0.07 | +10.4% | Beat |
| 25 Feb 2026 06:00 | 0.05 | 0.09 | +64.3% | Beat |
| 06 Nov 2025 06:00 | 0.04 | 0.01 | -63.7% | Miss |
| 07 Aug 2025 06:00 | 0.03 | 0.03 | -0.9% | In line |
| 07 May 2025 06:00 | 0.01 | 0.05 | +311.6% | Beat |
| 27 Feb 2025 06:00 | — | 0.02 | +501.6% | Beat |
| 07 Nov 2024 06:00 | -0.01 | 0.03 | +291.2% | Beat |
| 08 Aug 2024 06:00 | -0.01 | 0.01 | +221.6% | Beat |
| 09 May 2024 06:00 | -0.01 | — | +80.0% | — |
| 28 Feb 2024 06:00 | -0.01 | -0.02 | -64.5% | Miss |
| 08 Nov 2023 06:00 | -0.02 | -0.02 | -11.3% | Miss |
| 09 Aug 2023 06:00 | -0.02 | -0.03 | -11.5% | Miss |
| 10 May 2023 06:00 | -0.03 | -0.03 | -24.3% | Miss |
| 08 Mar 2023 06:00 | -0.03 | -0.03 | -2.3% | Miss |
| 08 Nov 2022 16:00 | -0.01 | -0.02 | -57.6% | Miss |
| 09 Aug 2022 16:00 | -0.02 | -0.03 | -38.7% | Miss |
| 09 May 2022 16:00 | -0.04 | -0.02 | +53.2% | Beat |
| 10 Mar 2022 16:00 | -0.02 | -0.02 | +17.5% | Beat |
| 08 Nov 2021 16:00 | -0.02 | -0.35 | -1,668.2% | Miss |
| 11 Aug 2021 16:00 | -0.05 | -0.06 | -18.2% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 1.4B | +13.9% | 9.7M | 0.7% | 0.02 | +113.3% | 110M |
| 2024 | 1.3B | +18.5% | -57.4M | -4.6% | -0.15 | +70.6% | 85.7M |
| 2023 | 1.1B | +22.8% | -186.3M | -17.6% | -0.51 | +16.4% | -57.4M |
| 2022 | 859.5M | — | -215.6M | -25.1% | -0.61 | — | -26.5M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 13.50 | 15.66 | 13.18 | 14.15 | +5.60% | 97,081,100 | |
| Oct 2026 | 12.04 | 13.76 | 11.47 | 13.40 | +11.39% | 66,920,600 | |
| Sep 2026 | 12.27 | 13.56 | 11.60 | 12.03 | -2.67% | 121,243,600 | |
| Aug 2026 | 10.63 | 12.97 | 10.08 | 12.36 | +17.94% | 93,599,400 | |
| Jul 2026 | 10.71 | 11.76 | 10.40 | 10.48 | -2.15% | 69,058,900 | |
| Jun 2026 | 7.72 | 10.89 | 7.29 | 10.71 | +38.91% | 76,649,400 | |
| May 2026 | 7.60 | 8.89 | 7.18 | 7.71 | +1.85% | 116,225,500 | |
| Apr 2026 | 6.37 | 7.77 | 6.21 | 7.57 | +18.84% | 81,342,500 | |
| Mar 2026 | 7.17 | 7.42 | 6.21 | 6.37 | -12.02% | 53,051,600 | |
| Feb 2026 | 7.17 | 8.09 | 6.46 | 7.24 | +2.40% | 49,667,400 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- LFST Q3 2026 deep dive: specialty services, clinician expansion, and EHR transition shape outlook (opens in a new tab) StockStory · 10 Nov 2026 10:29
- LifeStance Health Group, Inc. 2026 Q3 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 09 Nov 2026 18:23
- Surging Earnings Estimates Signal Upside for LifeStance Health (LFST) Stock (opens in a new tab) Zacks · 09 Nov 2026 16:20
- LifeStance Health Group Announces Pricing of Secondary Public Offering (opens in a new tab) 09 Nov 2026 14:00
- LifeStance Health Group Announces Launch of Secondary Public Offering (opens in a new tab) 09 Nov 2026 11:54
- LifeStance Health Group Prices Secondary Offering Of 45M Common shares At $13.12 Per Share (opens in a new tab) Benzinga · 09 Nov 2026 10:07
- LifeStance Health Stockholders Launch Secondary Offering Of 45M Shares; Company Authorizes Concurrent Repurchase of 2M Shares (opens in a new tab) Benzinga · 09 Nov 2026 07:56
- Why LifeStance Health Group (LFST) Moved Today (opens in a new tab) Simply Wall St. · 07 Nov 2026 10:12
- What Makes LifeStance Health Group (LFST) a Strong Momentum Stock: Buy Now? (opens in a new tab) Zacks · 06 Nov 2026 16:00
- Canaccord Genuity Maintains Buy on LifeStance Health Gr, Raises Price Target to $16 (opens in a new tab) Benzinga · 06 Nov 2026 15:27
- LifeStance Health Group, Inc. (LFST) Hits Fresh High: Is There Still Room to Run? (opens in a new tab) Zacks · 06 Nov 2026 13:15
- Keybanc Maintains Overweight on LifeStance Health Gr, Raises Price Target to $17 (opens in a new tab) Benzinga · 06 Nov 2026 10:32
- What LifeStance Health Group (LFST) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 06 Nov 2026 08:14
- LifeStance Health Group Inc (LFST) (Q3 2026) Earnings Call Highlights: Revenue Jumps 25% as ... (opens in a new tab) GuruFocus.com · 06 Nov 2026 01:13
- LifeStance (LFST) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 05 Nov 2026 20:17
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 14.37 USD
- Market cap
- 5.4B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 25.0 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 0.9 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 13.8 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 3.9 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 8.4 / 10 |
|
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A).
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 79.83× | Weak | 30.56× |
| P/E (forward) | 33.36× | Weak | 14.16× |
| Price / book | 3.66× | Weak | 3.5× |
| Price / sales | 3.26× | Fair | 3.33× |
| EV / EBITDA | 34.92× | Weak | 11.19× |
| Free cash flow yield | 3.1% | Fair | 2.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 34.4% | Fair | 54.9% |
| Operating margin | 6.4% | Weak | 5.8% |
| Net margin | 4.3% | Weak | 1.2% |
| Return on equity | 4.8% | Weak | 4.4% |
| Return on assets | 3.1% | Fair | 2.7% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 18.3% | Good | 10.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.32× | Good | 0.4× |
| Net debt / EBITDA | 1.57× | Fair | 1.46× |
| Interest cover | 2.07× | Weak | 2.17× |
| Current ratio | 1.44× | Fair | 2.64× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Similar shares
Follow LFST and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.